Comments

Passage Bio Stock Price, Quotes and Forecasts

Q: What sector and industry does Passage Bio (PASG) operate in?

Passage Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

PASGNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$0.3625

0.000600.17%

At close: -

$0.3750

0.013.45%

After Hours: 7:45 PM EDT

Passage Bio (PASG) Forecast

News Earnings Passage Bio (PASG) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Passage Bio Stock Price, Quotes and Forecasts | NASDAQ:PASG | Benzinga

Explore Passage Bio stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for PASG.

Open	$0.36
Close	$0.36
Volume / Avg.	62.83K / 172.26K
Day Range	$0.35 - $0.38
52 Wk Range	0.30 - 1.64
Market Cap	$23.16M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	44
Short Interest	3.4%
Days to Cover	10.91

Recent News

Why BlackBerry Shares Are Trading Lower By Over 5%; Here Are 20 Stocks Moving Premarket

Shares of BlackBerry Limited (NYSE: BB) moved lower in pre-market trading following the release of third-quarter results.

Avi Kapoor

Neurology-Focused Passage Bio Reveals Initial Data From Dementia Study, Outlines Strategic Priorities

Passage Bio Inc (NASDAQ: PASG) announced initial safety and biomarker data from three Cohort 1 patients in the ongoing global Phase 1/2 upliFT-D clinical trial evaluating PBFT02, an adeno-associated virus (AAV)-delivery gene therapy for frontotemporal dementia (FTD) with

Vandana Singh

Monday.Com To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Nov 24

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$0.36
Close	$0.36
Volume / Avg.	62.83K / 172.26K
Day Range	$0.35 - $0.38
52 Wk Range	0.30 - 1.64
Market Cap	$23.16M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	44
Short Interest	3.4%
Days to Cover	10.91

About Passage Bio Inc

Sector

Health Care

Industry

Biotechnology

Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative ...

Got Questions? Ask

Compare PASG performance to the market?

What is PASG's current ratio?

What is PASG's free cash flow?

What is the Pivot support level for PASG?

What’s driving PASG's recent performance?

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Passage Bio (PASG) stock?

You can purchase shares of Passage Bio (NASDAQ:PASG) through any online brokerage.

View our list of the best stock brokerages

Who are Passage Bio (PASG) competitors?

Other companies in Passage Bio’s space includes: Aligos Therapeutics (NASDAQ:ALGS), Nanoviricides (AMEX:NNVC), Barinthus Biotherapeutics (NASDAQ:BRNS), FibroGen (NASDAQ:FGEN) and OS Therapies (AMEX:OSTX).

What is the forecast, or price target, for Passage Bio (PASG) stock?

Passage Bio has a consensus price target of $7.29.

What is the current price for Passage Bio (PASG)?

The stock price for Passage Bio (NASDAQ: PASG) is $0.375 last updated April 11, 2025 at 7:45 PM EDT.

Does Passage Bio (PASG) pay a dividend?

There are no upcoming dividends for Passage Bio.

When is Passage Bio (NASDAQ:PASG) reporting earnings?

Passage Bio’s Q1 earnings are confirmed for Tuesday, May 13, 2025.

Is Passage Bio (PASG) going to split?

There is no upcoming split for Passage Bio.

What sector and industry does Passage Bio (PASG) operate in?

Passage Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.